Discussing the science behind Cleerly's new standard of care for heart disease.

evaluation of atherosclerotic plaque

3 min read

Q&A with Dr. James Earls: New Clinical Research Shared at ACC.23/WCC

Cleerly attended the American College of Cardiology conference (ACC.23/WCC) to showcase our efforts in providing a safe and effective approach to understanding cardiovascular disease risk and guiding personalized treatment. Our team presented compelling...

Read More »

4 min read

Atherosclerosis Treatment Algorithms for Heart Disease Evaluation

Quantification of coronary artery disease (CAD) burden and atherosclerotic plaque type has been shown to be the strongest determinant of future risk of major adverse cardiac events (MACE).1 Until recently, though, there had been no clinically useful...

Read More »

Advancing Equity Through Precision Heart Care

Cleerly Episode Featured on the AHA's Advancing Health Podcast Series

Dr. Leon D. Caldwell, Senior Director, Health Equity Strategies and Innovation, in the Institute of Diversity and Health Equity at the AHA, sits down with Dr. James Min, CEO and...

Read More »